HODDI:用于计算药物警戒的高阶药物-药物相互作用数据集
HODDI: A Dataset of High-Order Drug-Drug Interactions for Computational Pharmacovigilance
AI总结:
针对高阶药物相互作用数据集稀缺的问题,该研究构建了首个基于FDA FAERS十年记录的高阶药物-药物相互作用数据集HODDI,通过统计分析和模型评估验证其有效性,为药物警戒等研究提供基准资源。
摘要:
药物副作用研究对于理解复杂多药疗法中出现的不良反应至关重要。然而,能够捕捉多种药物组合效应的高阶数据集的稀缺严重限制了该领域的进展。现有资源如TWOSIDES主要关注成对相互作用。为填补这一关键空白,我们引入HODDI——首个高阶药物-药物相互作用数据集,该数据集基于美国食品药品监督管理局(FDA)不良事件报告系统(FAERS)过去十年的记录构建,旨在推动计算药物警戒的发展。HODDI包含109,744条记录,涉及2,506种独特药物和4,569种独特副作用,专门用于捕捉多药相互作用及其对不良反应的集体影响。全面的统计分析表明HODDI具有广泛的覆盖范围和稳健的分析指标,使其成为研究高阶药物关系的宝贵资源。通过多种模型对HODDI进行评估,我们发现简单的多层感知机(MLP)可优于图模型,而超图模型在捕捉复杂多药相互作用方面表现出更优性能,进一步验证了HODDI的有效性。我们的研究结果凸显了高阶信息在药物副作用预测中的内在价值,并将HODDI定位为推动药物警戒、药物安全和个性化医学研究的基准数据集。数据集和代码可在https://github.com/TIML-Group/HODDI获取。
英文摘要:
Drug-side effect research is vital for understanding adverse reactions arising in complex multi-drug therapies. However, the scarcity of higher-order datasets that capture the combinatorial effects of multiple drugs severely limits progress in this field. Existing resources such as TWOSIDES primarily focus on pairwise interactions. To fill this critical gap, we introduce HODDI, the first Higher-Order Drug-Drug Interaction Dataset, constructed from U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) records spanning the past decade, to advance computational pharmacovigilance. HODDI contains 109,744 records involving 2,506 unique drugs and 4,569 unique side effects, specifically curated to capture multi-drug interactions and their collective impact on adverse effects. Comprehensive statistical analyses demonstrate HODDI's extensive coverage and robust analytical metrics, making it a valuable resource for studying higher-order drug relationships. Evaluating HODDI with multiple models, we found that simple Multi-Layer Perceptron (MLP) can outperform graph models, while hypergraph models demonstrate superior performance in capturing complex multi-drug interactions, further validating HODDI's effectiveness. Our findings highlight the inherent value of higher-order information in drug-side effect prediction and position HODDI as a benchmark dataset for advancing research in pharmacovigilance, drug safety, and personalized medicine. The dataset and codes are available at https://github.com/TIML-Group/HODDI.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。